The National Institute of Allergy and Infectious Diseases (NIAID) intend to procure from Life Technologies corp. the following:  eight hundred and thirty-five (835) each of 12347019 293FECTIN, 1 ML. Transfection Reagent.  This reagent is specific for suspension 293 cell lines.  It provides the highest yields of protein expression for the 293 freestyle system of suspension 293 cells.  These cells are transfected with plasmid DNA using the 293fectin reagent.  The Vaccine Research Center has been using this reagent from Life Technologies and it has proven to support high production of the proteins that are required for its protocols in the development of vaccines for HIV and other viruses.  It is essential to maintain past reagent protocols and standards to ensure experimental results are not influenced by other variable.

 This will be a firm fixed price contract in accordance with the statutory authority for this sole source requirement 41 U.S.C. 253 (c) (1) as implemented by FAR 6.302-1 only one source available, no substitutions possible, and this item contains proprietary information. THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION; QUOTATIONS ARE BEING REQUESTED, AND A WRITTEN SOLICITATION WILL NOT BE ISSUED.  The incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2005-76, dated July 25, 2014.  The associated North American Industry Classification System (NAICS) Code is 325414, which has a size standard of 500 employees.  All responsible sources who feel they can meet these requirements shall submit an offer that will be considered by the Agency.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.  Offers must be submitted no later than 5:00 P.M. Eastern Time Monday, August 25, 2014 through the U.S. Postal Service at the address of NIH/NIAID/AMOB, 10401 Fernwood Road, Room 2NE52F, MSC 4811, Bethesda, MD, 20817.   Email and fax submissions are acceptable.  Point of contact concerning this requirement is James Kish, who can be reached by phone at 301-402-2282, f 301-480-8720, or e-mailed to [email protected].  Collect calls will not be accepted.